Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 3,300 shares at $18.65 ($61K) on 2019-07-23, disclosed to the SEC on 2019-07-24.
Scheduled sale ($61k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.57 | 1,400 | $26K | 42.3% |
| 2 | $18.65 | 1,900 | $35K | 57.7% |
| Total | $18.62 avg | 3,300 | $61K | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |